tiprankstipranks
Humacyte (HUMA)
NASDAQ:HUMA
US Market
Holding HUMA?
Track your performance easily

Humacyte (HUMA) Income Statement

946 Followers

Humacyte Income Statement

Last quarter (Q3 2024), Humacyte's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Humacyte's net income was $-39.20M. See Humacyte’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
--$ 1.56M$ 1.26M
Cost of Revenue
----
Gross Profit
--$ 1.56M$ 1.26M
Operating Expense
$ 112.49M$ 96.94M$ 84.58M$ 82.47M
Operating Income
$ -112.48M$ -100.00M$ -84.60M$ -81.20M
Net Non Operating Interest Income Expense
$ 853.00K$ -1.13M$ -3.57M$ -4.33M
Other Income Expense
$ 36.28M$ -12.70M$ 76.18M$ -60.33M
Pretax Income
$ -147.92M$ -110.78M$ -11.96M$ -26.48M
Tax Provision
$ -2.07M$ -2.07M$ -1.77M$ -1.71M
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -152.87M$ -110.78M$ -11.96M$ -26.48M
Basic EPS
$ -1.34$ -1.07$ -0.12$ -0.66
Diluted EPS
$ -1.34$ -1.07$ -0.12$ -0.66
Basic Average Shares
$ 450.44M$ 103.42M$ 103.05M$ 39.97M
Diluted Average Shares
$ 450.44M$ 103.42M$ 103.05M$ 39.97M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 112.49M$ 96.94M$ 84.58M$ 82.47M
Net Income From Continuing And Discontinued Operation
$ -152.87M$ -110.78M$ -11.96M$ -26.48M
Normalized Income
$ -111.78M$ -102.80M--
Interest Expense
----
EBIT
$ -149.32M$ -104.18M$ -5.76M$ -22.13M
EBITDA
$ -142.07M$ -96.46M$ 2.44M$ -13.89M
Currency in USD

Humacyte Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis